Drug Shortage Report for VIOKACE

Last updated on 2019-01-29 History
Report ID 73777
Drug Identification Number 02230019
Brand name VIOKACE
Common or Proper name Viokace
Company Name APTALIS PHARMA CANADA ULC
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 56400UNIT 57100UNIT 10440UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's count bottle
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-02-15
Actual start date
Estimated end date 2019-04-19
Actual end date 2019-01-29
Shortage status Avoided shortage
Updated date 2019-01-29
Company comments Delay with product release and raw material replenishment. Viokace 10440 will remain available to alleviate impact.
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-01-29 French Compare
v3 2019-01-29 English Compare
v2 2019-01-29 French Compare
v1 2019-01-29 English Compare